~101 spots leftby Dec 2030

Deep Brain Stimulation for Movement Disorders

Recruiting in Palo Alto (17 mi)
+1 other location
DJ
Overseen byDebra J Ehrlich, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Must be taking: Dopaminergic medication
Must not be taking: Neuroleptics
Disqualifiers: Uncontrolled hypertension, Dementia, Pregnancy, others
No Placebo Group
Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

Background: - In deep brain stimulation (DBS), a device called a neurostimulator is placed in the chest. It is attached to wires in parts of the brain that affect movement. DBS might help people with movement disorders like Parkinson s disease (PD), dystonia, and essential tremor (ET). Objective: - To provide DBS treatment to people with some movement disorders. Eligibility: - Adults 18 years and older with PD, ET, or certain forms of dystonia. Design: * Participants will be screened with medical history and physical exam. They will have blood and urine tests and: * MRI brain scan. The participant will lie on a table that slides in and out of a metal cylinder with a magnetic field. They will be in the scanner about 60 minutes. They will get earplugs for the loud noises. During part of the MRI, a needle will guide a thin plastic tube into an arm vein and a dye will be injected. * Electrocardiogram. Metal disks or sticky pads will be placed on the chest, arms, and legs. They record heart activity. * Chest X-ray. * Tests of memory, attention, concentration, thinking, and movement. * Eligible participants will have DBS surgery. The surgery and hospital care afterward are NOT part of this protocol. * Study doctors will see participants 3 4 weeks after surgery to turn on the neurostimulator. * Participants will return every month for 3 months, then every 3 months during the first year, and every 6 months during the second year. Each time, participants will be examined and answer questions. DBS placement will be evaluated with MRI. The neurostimulator will be programmed. At two visits, participants will have tests of movements, thinking, and memory.

Will I have to stop taking my current medications?

The trial protocol does not specify if you need to stop taking your current medications. However, it mentions that participants should have an unsatisfactory response to their current medical management, which might imply some changes could be necessary. It's best to discuss your specific medications with the study doctors.

What data supports the effectiveness of the treatment Deep Brain Stimulation for movement disorders?

Deep Brain Stimulation (DBS) is shown to be highly effective for treating movement disorders like essential tremor, Parkinson's disease, and dystonia. Studies indicate that DBS can reduce tremor severity by about 50% and improve motor symptoms and quality of life significantly in patients with these conditions.12345

Is Deep Brain Stimulation generally safe for humans?

Deep Brain Stimulation (DBS) is generally well-tolerated, but it can have complications such as infections (2-16.2%), bleeding in the brain (1-6.3%), and seizures (1-3%). Some patients may need additional surgery to fix or remove the device if problems occur.678910

How is Deep Brain Stimulation different from other treatments for movement disorders?

Deep Brain Stimulation (DBS) is unique because it uses electrical impulses to modulate specific brain regions in a reversible and adjustable way, unlike other treatments that may involve permanent changes or medications. It is particularly effective for advanced movement disorders like Parkinson's disease, essential tremor, and dystonia, offering an option when medications are no longer effective.23111213

Research Team

DJ

Debra J Ehrlich, M.D.

Principal Investigator

National Institute of Neurological Disorders and Stroke (NINDS)

Eligibility Criteria

This trial is for adults over 18 with Parkinson's Disease (PD), essential tremor (ET), or certain dystonias who've had a good response to dopaminergic meds for PD. It's not suitable for those with significant medical risks, secondary movement disorders, dementia, pregnancy, psychiatric issues, or an inability to undergo MRI scans.

Inclusion Criteria

I am considering or already have a deep brain stimulation device for my movement disorder.
I am 18 years old or older.
Able to comply with study procedures and provide informed consent
See 2 more

Exclusion Criteria

Dementia, cognitive impairments, or unstable psychiatric disorders
I have serious health conditions that could make treatment risky.
I have unusual or secondary movement disorders like shaking or stiffness.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Surgery and Initial Programming

Eligible participants will have DBS surgery. Study doctors will see participants 3-4 weeks after surgery to turn on the neurostimulator.

4 weeks
1 visit (in-person)

Follow-up

Participants will return every month for 3 months, then every 3 months during the first year, and every 6 months during the second year. Each time, participants will be examined and answer questions. DBS placement will be evaluated with MRI. The neurostimulator will be programmed.

2 years
Multiple visits (in-person)

Long-term Follow-up

Participants have the option to transfer their care back to the neurologists in the community or continue care with the NIH Neurology team until care in the community is available.

Ongoing

Treatment Details

Interventions

  • Deep Brain Stimulation (Procedure)
  • Deep Brain Stimulation Management (Procedure)
Trial OverviewThe study tests Deep Brain Stimulation (DBS) therapy in managing movement disorders. Participants will have DBS surgery followed by regular check-ups where the neurostimulator settings are adjusted based on their condition and responses assessed through various physical and cognitive tests.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single-armExperimental Treatment1 Intervention
Therapy

Deep Brain Stimulation is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Deep Brain Stimulation for:
  • Essential tremor
  • Parkinson's disease
  • Dystonia
  • Obsessive-compulsive disorder
  • Epilepsy
  • Chronic pain

Find a Clinic Near You

Who Is Running the Clinical Trial?

National Institute of Neurological Disorders and Stroke (NINDS)

Lead Sponsor

Trials
1,403
Recruited
655,000+

Jordan Gladman

National Institute of Neurological Disorders and Stroke (NINDS)

Chief Medical Officer

MD from Harvard Medical School

Walter J. Koroshetz profile image

Walter J. Koroshetz

National Institute of Neurological Disorders and Stroke (NINDS)

Chief Executive Officer since 2007

MD from the University of Chicago

Findings from Research

Deep brain stimulation (DBS) is highly effective for treating advanced movement disorders, with essential tremor patients experiencing an average tremor reduction of about 50% over 1 to 5 years.
In patients with dystonia, DBS can lead to a significant decrease in motor severity scores by 50% to 80% over 2 to 3 years, with serious adverse events being rare, highlighting its safety and efficacy.
Surgical considerations for tremor and dystonia.Cooper, S., Bowes, M.[2012]
Deep brain stimulation (DBS) has proven to be a safe and effective treatment for movement disorders, particularly essential tremor and advanced Parkinson's disease, significantly improving patient outcomes.
Vim DBS has largely replaced thalamotomy for essential tremor, while STN and GPi DBS enhance 'on' time without dyskinesias in Parkinson's patients, indicating a shift towards more effective surgical options in managing these conditions.
Advances in neurostimulation for movement disorders.Gross, RE., Lozano, AM.[2019]
Deep brain stimulation (DBS) is an effective treatment for movement disorders like Parkinson's disease and epilepsy, with ongoing advancements in both open-loop and closed-loop systems.
Recent research is increasingly focusing on closed-loop DBS systems, which may offer improved outcomes by adapting stimulation based on real-time feedback from the patient's brain activity.
Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease.Wu, YC., Liao, YS., Yeh, WH., et al.[2022]

References

Surgical considerations for tremor and dystonia. [2012]
Advances in neurostimulation for movement disorders. [2019]
Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease. [2022]
Hardware complications in deep brain stimulation: electrode impedance and loss of clinical benefit. [2012]
Movement disorders and neuromodulation. [2022]
Complications of deep brain stimulation in Parkinson's disease: a single-center experience of 517 consecutive cases. [2023]
Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures. [2019]
Administration of electroconvulsive therapy for depression associated with deep brain stimulation in a patient with post-traumatic Parkinson's Disease: a case study. [2018]
Intracerebral abscess: a rare complication of Deep Brain Stimulation. [2013]
10.United Statespubmed.ncbi.nlm.nih.gov
Characterizing Complications of Deep Brain Stimulation Devices for the Treatment of Parkinsonian Symptoms Without Tremor: A Federal MAUDE Database Analysis. [2023]
Radiofrequency Lesions through Deep Brain Stimulation Electrodes in Movement Disorders: Case Report and Review of the Literature. [2018]
[Deep brain stimulation in the treatment of movement disorders]. [2008]
[Deep brain stimulation in movement disorders: evidence and therapy standards]. [2018]